Jacobs Levy Equity Management, Inc Arcturus Therapeutics Holdings Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 495,291 shares of ARCT stock, worth $7.37 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
495,291
Previous 144,141
243.62%
Holding current value
$7.37 Million
Previous $1.53 Million
322.21%
% of portfolio
0.03%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding ARCT
# of Institutions
169Shares Held
25.9MCall Options Held
289KPut Options Held
109K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$69.9 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$39.5 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$27.3 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$27.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$27 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $396M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...